United Kingdom 2024
Medical Device Updates
4th December 2024 – AI Airlock Update: Five AI-Enabled Devices Selected
- AI Airlock, the UK’s first regulatory sandbox for AI medical devices, selected five cutting-edge technologies:
- Lenus Stratify (Lenus Health) – AI-driven COPD risk prediction.
- Existing Radiology Systems (Philips) – AI-integrated radiology reporting.
- FAMOS (Newton’s Tree) – Real-time AI performance monitoring.
- OncoFlow (UMA Advisory) – Cancer treatment planning AI.
- SmartGuideline (Automedica) – AI-powered healthcare knowledge database.
- Part of the UK’s 10-year digital health strategy.
6th December 2024 – Revised Regulatory Reform Roadmap Released
- Key updates:
- PMS Regulations effective 16th June 2025.
- Extended CE mark acceptance:
- Medical Devices – until 30th June 2028.
- IVDs – until 30th June 2030.
- Pre-market regulations coming in 2025 and 2026.
- New AI & digital health guidance expected, covering cybersecurity, AI development, and Good Machine Learning Practice (GMLP).
-
12th December 2024 – New Clinical Trials Legislation Laid in Parliament
Goals:
- Reduce administrative burdens on sponsors.
- Encourage internationally aligned clinical trial standards.
- Streamline MHRA processing times.
Key focus areas:
- Public health and participant safety.
- Efficient evaluation of life-changing medicines.
16th December 2024 – PMS SI Becomes Law
- The Medical Devices (Post-market Surveillance Requirements) (Amendment) Regulations 2024 is now legally binding.
New obligations for manufacturers:
- Enhanced data collection and shorter incident reporting times.
- Mandatory Post-Market Surveillance (PMS) Plans.
- Stronger patient and public engagement requirements.
- Periodic Safety Update Reports (PSURs) now required.
-
United States 2024
Medical Device Updates
3rd December 2024 – FDA Issues Guidance on AI Change Control Plans
- Predetermined Change Control Plan (PCCP) now required for AI-enabled medical devices.
Manufacturers must document:
- Planned AI modifications.
- Risk assessments and ongoing performance monitoring.
4th December 2024 – Latest FDA Sterilization Town Hall
Key discussions:
- Transition away from ethylene oxide (EtO) sterilization.
- Use of vaporized hydrogen peroxide for sterilization.
17th December 2024 – FDA Releases GUDID Guidance
Global Unique Device Identification Database (GUDID) updated to improve:
- Device traceability and recall efficiency.
- Global harmonization of medical device tracking.
20th December 2024 – FDA Releases Clinical Decision Support (CDS) Software FAQs
- Clarifies when CDS software is classified as a medical device
- Essential for manufacturers assessing regulatory obligations.
30th December 2024 – FDA Unveils ‘Home as a Healthcare Hub’ Initiative
- New “Idea Lab” launched to explore medical device use in home settings.
- Aims to enhance home healthcare solutions amid rising demand for remote patient monitoring.
European Union 2024
Medical Device Updates
2nd December 2024 – MDCG 2024-15 Released: Clinical Investigation Reporting
Guidance for manufacturers on reporting clinical investigations in the absence of EUDAMED.
Requirements:
- Reports must be submitted within 12 months of study completion.
- Immediate public access to reports via national authorities.
6th December 2024 – MDCG 2024-16: Supply Chain Disruptions Reporting
- New obligations for manufacturers to report interruptions in supply.
- Applies to devices where shortages could cause serious patient harm.
12th December 2024 – European Commission Opens Public Consultation on Medical Device Regulations
Focus:
- Effectiveness and impact of MDR/IVDR.
- Associated costs and regulatory burden.
- Feedback open until 21st March 2025.
18th December 2024 – MDCG 2022-3 Rev 1: Updates to Class D IVD Verification
- Clarifications on batch testing, direct manufacturer agreements with EU Reference Labs, and revised risk classification for calibrators and controls.
-
Q&A on Medical Device Supply Interruption
-
Mandatory reporting of supply chain disruptions begins 10th January 2025.
- Economic operators must relay supply warnings to health institutions and professionals.

